secwatch.observer — SEC 8-K summary
======================================

Issuer:     QUEST DIAGNOSTICS INC (DGX)
CIK:        0001022079
Form:       8-K
Filed at:   2023-07-26T23:59:59+00:00
Accession:  0001022079-23-000131
Event type: earnings
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quest Diagnostics Q2 revenue $2.34B down 4.7% YoY; base business up 9.5%; raises FY revenue guidance
--------------------------------------------------------------------------------

- Q2 reported EPS $2.05 (+4.6% YoY); adjusted EPS $2.30 (-2.5% YoY).
- Base business revenue $2.30B (+9.5% YoY); COVID testing revenue $41M (-88.3%).
- FY 2023 revenue guidance raised to $9.12B-$9.22B (from $8.93B-$9.08B).
- Adjusted EPS guidance $8.50-$8.90; cash from operations at least $1.3B.
- CEO cites strong base business demand but persistent labor turnover pressures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022079/000102207923000131/0001022079-23-000131-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022079/000102207923000131/dgx-20230726.htm
  HTML page:      https://secwatch.observer/filing/0001022079-23-000131

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer